Usana Health Sciences Inc (USNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 42,060 | 63,788 | 69,350 | 116,505 | 124,664 |
| Depreciation Amortization | 22,229 | 20,395 | 21,410 | 22,193 | 22,509 |
| Income taxes - deferred | -6,744 | -2,749 | -7,183 | -2,970 | -2,423 |
| Accounts payable and accrued liabilities | -1,269 | -428 | -2,656 | -4,572 | 6,076 |
| Other Working Capital | -13,003 | -27,999 | 771 | -33,060 | 556 |
| Other Operating Activity | 17,719 | 17,634 | 22,210 | 23,131 | 9,019 |
| Operating Cash Flow | $60,992 | $70,641 | $103,902 | $121,227 | $160,401 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10,009 | -14,479 | -10,393 | -12,748 | -15,088 |
| Net Acquisitions | -203,336 | N/A | -6,532 | N/A | N/A |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -20,000 |
| Other Investing Activity | 255 | 2,504 | 4,555 | -1,439 | 1,127 |
| Investing Cash Flow | $-213,090 | $-11,975 | $-12,370 | $-14,187 | $-33,961 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 23,687 | 1,542 | 11,000 | 0 | 60,000 |
| Common Stock Repurchased | -9,444 | -11,599 | -25,382 | -177,837 | -57,029 |
| Other Financing Activity | -4,690 | -4,180 | -15,706 | -3,575 | -62,413 |
| Financing Cash Flow | $9,553 | $-14,237 | $-30,088 | $-181,412 | $-59,442 |
| Exchange Rate Effect | -6,193 | -2,503 | -13,777 | 2,088 | 11,251 |
| Beginning Cash Position | 333,246 | 291,320 | 243,653 | 315,937 | 237,688 |
| End Cash Position | 184,508 | 333,246 | 291,320 | 243,653 | 315,937 |
| Net Cash Flow | $-148,738 | $41,926 | $47,667 | $-72,284 | $78,249 |
| Free Cash Flow | |||||
| Operating Cash Flow | 60,992 | 70,641 | 103,902 | 121,227 | 160,401 |
| Capital Expenditure | -10,073 | -14,494 | -10,400 | -12,763 | -15,094 |
| Free Cash Flow | 50,919 | 56,147 | 93,502 | 108,464 | 145,307 |